Abstract
The paper gives data on the use of the nonsteroidal anti-inflammatory drug (NSAID) aceclofenac (Airtal) for nonspecific back pain and other diseases. Aceclofenac is noted to be as effective as the most known nonselective NSAIDs (diclofenac, naproxen, indomethacin), at the same time it causes much lower rate of adverse gastrointestinal reactions, including hemorrhage. The authors also provide an analysis of serious side effects of NSAIDs in several countries, which shows that aceclofenac is one of the safest NSAIDs.
Highlights
The paper gives data on the use of the nonsteroidal anti-inflammatory drug (NSAID) aceclofenac (Airtal) for nonspecific back pain and other diseases
The authors provide an analysis of serious side effects of NSAIDs in several countries, which shows that aceclofenac is one of the safest NSAIDs
нестероидный противовоспалительный препарат (НПВП) не комбинируют друг с другом, не применяют длительно, при неспецифической боли в спине их прием ограничивают 10—14 днями, что существенно снижает риск развития осложнений со стороны желудочно-кишечного тракта (ЖКТ), сердечно-сосудистой системы и др
Summary
The paper gives data on the use of the nonsteroidal anti-inflammatory drug (NSAID) aceclofenac (Airtal) for nonspecific back pain and other diseases. НПВП не комбинируют друг с другом, не применяют длительно, при неспецифической боли в спине их прием ограничивают 10—14 днями, что существенно снижает риск развития осложнений со стороны ЖКТ, сердечно-сосудистой системы и др.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.